0001127602-12-015815.txt : 20120503 0001127602-12-015815.hdr.sgml : 20120503 20120503175304 ACCESSION NUMBER: 0001127602-12-015815 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120501 FILED AS OF DATE: 20120503 DATE AS OF CHANGE: 20120503 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: QUEST DIAGNOSTICS INC CENTRAL INDEX KEY: 0001022079 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 161387862 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3 GIRALDA FARMS CITY: MADISON STATE: NJ ZIP: 07940 BUSINESS PHONE: 9735202700 MAIL ADDRESS: STREET 1: 3 GIRALDA FARMS CITY: MADISON STATE: NJ ZIP: 07940 FORMER COMPANY: FORMER CONFORMED NAME: CORNING CLINICAL LABORATORIES INC DATE OF NAME CHANGE: 19960903 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BONGIORNO THOMAS F CENTRAL INDEX KEY: 0001222675 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-12215 FILM NUMBER: 12811183 MAIL ADDRESS: STREET 1: 3 GIRALDA FARMS CITY: MADISON STATE: NJ ZIP: 07940 4 1 form4.xml PRIMARY DOCUMENT X0305 4 2012-05-01 0001022079 QUEST DIAGNOSTICS INC DGX 0001222675 BONGIORNO THOMAS F C/O QUEST DIAGNOSTICS INCORPORATED 3 GIRALDA FARMS MADISON NJ 07940 1 VP and Corporate Controller Common Stock 2012-05-01 4 S 0 2305 58.4322 D 1 I By Ira Common Stock 10941 D Common Stock 3005 I 401k The amount of shares sold includes approximately 105 shares acquired via dividend reinvestment that were not previously reported in reporting person's beneficial ownership held indirectly by IRA. The dividend reinvestment plan, sponsored by a broker-dealer, essentially mirrors a dividend reinvestment plan sponsored by the registrant. The amount includes exempt purchases made under the Company's stock purchase plan. These underlying shares were acquired on a periodic basis by the trustee of the Company's tax qualified Profit Sharing Plan (401(k)). The information was obtained from the plan administrator as of a current date. The number of shares is based on the account balance of the Company stock fund under the Plan (which includes some money market instruments) divided by the market price of the Company stock as of that date. /s/ William J. O'Shaughnessy, Jr., Attorney in Fact for Thomas F. Bongiorno 2012-05-03